IRIDEX Corporation

Company Profile

IRIDEX Corporation had its IPO on 1996-02-15 under the ticker symbol IRIX.

The company operates in the Healthcare sector and Medical Devices industry. IRIDEX Corporation has a staff strength of 130 employees.

Stock update

Shares of IRIDEX Corporation opened at $1.87 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.79 - $1.91, and closed at $1.79.

This is a -4.28% slip from the previous day's closing price.

A total volume of 143,638 shares were traded at the close of the day’s session.

In the last one week, shares of IRIDEX Corporation have increased by +0.28%.

IRIDEX Corporation's Key Ratios

IRIDEX Corporation has a market cap of $30.84 million, indicating a price to book ratio of 1.9639 and a price to sales ratio of 0.6308.

In the last 12-months IRIDEX Corporation’s revenue was $56.39 million with a gross profit of $25.37 million and an EBITDA of $-7553000. The EBITDA ratio measures IRIDEX Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, IRIDEX Corporation’s operating margin was -14.44% while its return on assets stood at -12.33% with a return of equity of -47.27%.

In Q2, IRIDEX Corporation’s quarterly earnings growth was a positive 0% while revenue growth was a negative 6.5%.

IRIDEX Corporation’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

-0.44

Its diluted EPS in the last 12-months stands at $-0.49 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -0.44. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into IRIDEX Corporation’s profitability.

IRIDEX Corporation stock is trading at a EV to sales ratio of 0.379 and a EV to EBITDA ratio of -2.7106. Its price to sales ratio in the trailing 12-months stood at 0.6308.

IRIDEX Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$36.94 million

Total Liabilities

$12.24 million

Operating Cash Flow

$0

Capital Expenditure

$16000

Dividend Payout Ratio

0%

IRIDEX Corporation ended 2024 with $36.94 million in total assets and $0 in total liabilities. Its intangible assets were valued at $36.94 million while shareholder equity stood at $13.45 million.

IRIDEX Corporation ended 2024 with $0 in deferred long-term liabilities, $12.24 million in other current liabilities, 171000.00 in common stock, $-74328000.00 in retained earnings and $965000.00 in goodwill. Its cash balance stood at $9.82 million and cash and short-term investments were $9.82 million. The company’s total short-term debt was $1,049,000 while long-term debt stood at $0.

IRIDEX Corporation’s total current assets stands at $30.97 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $8.80 million compared to accounts payable of $4.28 million and inventory worth $11.13 million.

In 2024, IRIDEX Corporation's operating cash flow was $0 while its capital expenditure stood at $16000.

Comparatively, IRIDEX Corporation paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.79

52-Week High

$2.74

52-Week Low

$1.3104

Analyst Target Price

$3.88

IRIDEX Corporation stock is currently trading at $1.79 per share. It touched a 52-week high of $2.74 and a 52-week low of $2.74. Analysts tracking the stock have a 12-month average target price of $3.88.

Its 50-day moving average was $1.84 and 200-day moving average was $2.11 The short ratio stood at 1.64 indicating a short percent outstanding of 0%.

Around 2537.9% of the company’s stock are held by insiders while 2323.8% are held by institutions.